Elucidation of novel functions of cholesterol and its metabolites using genetic manipulation in mice
Elucidation of novel functions of cholesterol and its metabolites using genetic manipulation in mice
批准号:
17390266
负责人:
ISHIBASHI Shun
金额:
$8.84万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
2005
资助国家:
日本
项目状态:
已结题
起止时间:
2005 至 2007
中文摘要
胆固醇的生物合成途径分为两条途径:类固醇途径和非类固醇途径。然后非甾醇途径提供各种物质,如异戊二烯、二十二醇、血红素A和泛醌。HMG-CoA还原酶(HMGCR)产生甲伐他酸,它是固醇和非固醇途径的前体,而角鲨烯合成酶(SS)产生角鲨烯,而角鲨烯只参与固醇途径。在本研究中,我们使用Cre-loxP系统以肝脏特异的方式干扰HMGCR或SS的基因,以剖析肝脏中各自酶的功能。肝脏特异性HMGCR基因敲除小鼠(L-HMGCRKO)出生后1个月因暴发性肝功能衰竭而死亡。血浆胆固醇水平仅降低了10%,肝脏胆固醇的生物合成没有减少。诱导SREBP2基因表达,下调Cyp7A基因表达。肝细胞内充满甘油三酯。肝脏特异性SS基因敲除小鼠(L-SSKO)表现为一过性肝肿大并伴有肝功能障碍。尽管肝脏极低密度脂蛋白的生成率降低,但至少在体内环境下,肝脏胆固醇的生物合成并没有减少。综上所述,HMGCR对于正常的肝功能和生存是必不可少的,而SS是必不可少的。在两种模型中,正常的胆固醇生物合成都表明存在代谢旁路,在没有这些胆固醇生物合成关键酶的情况下,该途径会产生胆固醇。
英文摘要
Cholesterol biosynthetic pathway is divided into two pathways: sterol pathway and non-sterol pathway. Then non-sterol pathway supplies various substances such as isoprenoids, dolichol, Haem A and ubiquinones. HMG-CoA reductase (HMGCR) produces mevalonate which is a precursor of both sterol and non-sterol pathways, whereas squalene synthase (SS) produces squalene which contributes only to sterol pathway. In the present study, we used Cre-LoxP system to disrupt genes of HMGCR or SS in a liver-specific manner to dissect out the functions of the respective enzymes in the liver. Liver-specific HMGCR knockout mice (L-HMGCRKO) were lethal at 1 month after the birth due to fulminant hepatic failure. Plasma cholesterol levels were reduced only by 10% and hepatic cholesterol biosynthesis was not reduced. mRNA expression of SREBP2 was induced, while expression of Cyp7A was reduced. The hepatocytes were filled with triglycerides. Liver-specific SS knockout mice (L-SSKO) showed transient hepatomegaly with liver dysfunction. Although hepatic VLDL production rate was reduced, hepatic cholesterol biosynthesis was not reduced at least in in vivo setting. In conclusion, HMGCR is essential for normal liver function and survival, while SS is dispensable. Normal cholesterol biosynthesis in both models suggests the presence of metabolic bypass pathway which produces cholesterol in the absence of these key enzymes in cholesterol biosynthesis.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.2337/db05-0585
发表时间:
2006-07-01
期刊:
DIABETES
影响因子:
7.7
作者:
[Okazaki, Hiroaki, Igarashi, Masaki, Ishibashi, Shun]
通讯作者:
Ishibashi, Shun
DOI:
--
发表时间:
2008
期刊:
J Lipid Res 49
影响因子:
--
作者:
[Sekiya M, et.al.]
通讯作者:
et.al.
Cholesterol reduction and atherosclerosis of inhibition by bezafibrate in low density lipoprotein receptor knockout mice
苯扎贝特对低密度脂蛋白受体敲除小鼠的胆固醇降低和动脉粥样硬化抑制作用
DOI:
--
发表时间:
2008
期刊:
Hypertens Res (in press)
影响因子:
--
作者:
[Inaba, T., et. al.]
通讯作者:
et. al.
Ligand-independent activation of vascular endothelial growth factor receptor 1 by low-density lipoprotein.
低密度脂蛋白对血管内皮生长因子受体 1 的配体依赖性激活。
DOI:
--
发表时间:
2007
期刊:
EMBO Rep. 8
影响因子:
--
作者:
[Usui R, et. al.]
通讯作者:
et. al.
コレステロール合成系酵素群を欠損させた血管平滑筋細胞における増殖能の検討
缺乏胆固醇合成酶的血管平滑肌细胞增殖能力的检测
DOI:
--
发表时间:
2006
期刊:
影响因子:
--
作者:
[田副 文子, 他]
通讯作者:
他
共 7 条
Study on the endoplasmic stress induced by oxsterol ester and its implication to diseases
-
批准号:22390187
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$12.06万
-
财政年份:2010
-
负责人:ISHIBASHI Shun
-
依托单位:
New therapeutic targets for atherosclerotic plaques - The role of acyl CoA : cholesterol acyltransferase and neutral cholesterol ester hydrolase in foam cell formation
-
批准号:12557092
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$8.51万
-
财政年份:2000
-
负责人:ISHIBASHI Shun
-
依托单位:
Transgenic study on the heterogeneity of intacellular triacylglycerol lipase
-
批准号:11470232
-
项目类别:Grant-in-Aid for Scientific Research (B).
-
资助金额:$9.54万
-
财政年份:1999
-
负责人:ISHIBASHI Shun
-
依托单位:
Development of a novel animal model to investigate the role of cholesterol metabolism in the development and differentiation
-
批准号:10557104
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$8.7万
-
财政年份:1998
-
负责人:ISHIBASHI Shun
-
依托单位:
Development of basic techniques for the liver-directed gene therapy
-
批准号:07557071
-
项目类别:Grant-in-Aid for Scientific Research (A)
-
资助金额:$9.47万
-
财政年份:1995
-
负责人:ISHIBASHI Shun
-
依托单位:
海外基金